Fed Circuit refuses to hear $23m Medtronic loss
30-04-2019
Capricor acquires Medtronic patents to boost heart failure treatments
15-10-2014
23-09-2021
JHVEphoto / Shutterstock.com
The US Patent Trial and Appeal Board (PTAB) has confirmed the validity of three remaining Medtronic patents challenged by rival medical device manufacturer Axonics.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Medtronic, Axonics, PTAB, InterSim, PTAB, US District Court for the Central District of California